The mitochondrial spiral: An adequate cause of dementia in the Alzheimer's syndrome

Annals of the New York Academy of Sciences

Volumn 924, Issue , 2000, Pages 170-183

  Blass, John P ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b BURKE MEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

Calcium; Energy; KGDHC; Mitochondria; Reactive oxygen species

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CALCIUM; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; BRAIN METABOLISM; CALCIUM HOMEOSTASIS; CONFERENCE PAPER; DEMENTIA; GENE EXPRESSION; MITOCHONDRION; NERVE CELL DEGENERATION; NEUROPATHOLOGY; OXIDATIVE STRESS; OXYGEN SUPPLY;

EID: 0034512488     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb05576.x     Document Type: Conference Paper

References (81)

1. Pathophysiology of the Alzheimer syndrome
2. Metabolism of the aging brain
3. Cerebral metabolic impairments
4. Is Alzheimer's disease inevitable with age? Lessons from clinicopathologic studies of healthy aging and very mild Alzheimer's disease
5. Alzheimer neuropathologic alterations in aged cognitively normal subjects
6. Alzheimer dementia. A clinical long-term study with quantitative neuropathology
7. Brain dysfunction in mild to moderate hypoxia
8. Cerebrometabolic aspects of delirium in relationship to dementia
9. Dementia with bilateral medial temporal lobe ischemia
10. Cellular actions of β-amyloid precursor protein and its soluble and fibrillogenic derivatives
11. 4-Hydroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubule-associated protein tau
12. A mechanism for the neuroprotective effect of apolipoprotein E: Isoform-specific modification by the lipid peroxidation product 4-hydroxynonenal
13. Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: Involvement of perturbed calcium homeostasis
14. The role of oxidative stress in Alzheimer disease
15. Oxidative stress and a key metabolic enzyme in Alzheimer brains, cultured cells, and an animal model of chronic oxidative deficits
16. The α-ketoglutarate dehydrogenase complex
17. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease
18. Preclinical evidence of Alzheimer's disease in persons homozygous for the ε-4 allele for apolipoprotein E
19. Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype
20. Decreased medial temporal lobe oxygen metabolism in Alzheimer's disease shown by PET
21. The Role of Vascular Disease in Alzheimer's Disease
22. Absence of vascular dementia in an autopsy series from a dementia clinic
23. Vascular factors in cognitive impairment - Where are we now?
24. Hippocampal sclerosis contributes to dementia in the elderly
25. Atrophy of the hippocampal formation subdivisions correlates with stage and duration of Alzheimer's disease
26. MRI temporal lobe volume measures and neuropsychological function in Alzheimer's disease
27. Further characterization of patients with amnesia after cardiac arrest: Preserved recognition memory
28. Loss of hippocampal CA1 pyramidal neurons correlates with memory impairment in rats with ischemic or neurotoxin lesions
29. Inherent abnormalities in energy metabolism in Alzheimer disease. Interaction with cerebrovascular compromise
30. No mitochondrial haplotype was found to increase risk for Alzheimer's disease
31. Oxidative alterations in Alzheimer's disease
32. Downregulation of oxidative phosphorylation in Alzheimer disease: Loss of cytochrome oxidase subunit mRNA in the hippocampus and entorhinal cortex
33. Functional integrity of mitochondrial genomes in human platelets and autopsied brain tissues from elderly patients with Alzheimer's disease
34. Mitochondrial and nuclear gene expression for cytochrome oxidase are disproportionally regulated by functional activity in neurons
35. Brain protein and α-ketoglutarate dehydrogenase complex activity in Alzheimer's disease
36. Association between the gene encoding the E2 subunit of α-ketoglutarate dehydrogenase complex and Parkinson's disease
37. Frontal lobe dysfunction in progressive supranuclear palsy: Evidence for oxidative stress and mitochondrial impairment
38. Binding of human apolipoprotein E to synthetic amyloid beta peptide: Isoform-specific effects and implications for late-onset Alzheimer disease
39. A relationship of KGDHC activity to clinical disability in Alzheimer patients with an APOE4 genotype
40. Frontal lobe dysfunction in progressive supranuclear palsy: Evidence for oxidative stress and mitochondrial impairment
41. Preface
42. Oxidative/Energy Metabolism in Neurodegenerative Disorders
43. The aging paradox: Free radical theory of aging
44. Polymorphonuclear leukocytes modulate tissue factor production by mononuclear cells: Role of reactive oxygen species
45. Cell-permeable scavengers of superoxide prevent long-term potentiation in hippocampal area CA1
46. Desensitization of adenosine A1 receptor-mediated inhibition of adenylyl cyclase in cerebellar granule cells
47. Fundamental aspects of reactive oxygen species, or What's the matter with oxygen?
48. Influence of the antioxidants vitamin E and idebenone on retinal cell injury mediated by chemical ischemia, hypoglycemia, or oxidative stress
49. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease
50. Treatment of Alzheimer's disease - Searching for a breakthrough, settling for less
51. Calcium signaling in the ER: Its role in neuronal plasticity and neurodegenerative disorders
52. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases
53. Abnormalities in Alzheimer's disease fibroblasts bearing the APP670/671 mutation
54. The calcium response of human T lymphocytes is decreased in aging but increased in Alzheimer's dementia
55. Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: Involvement of perturbed calcium homeostasis
56. Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons
57. Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice
58. L-type calcium channels in the hippocampus and cerebellum of Alzheimer's disease brain tissue
59. Brain inflammation in Alzheimer disease and the therapeutic implications
60. Neuroinflammatory processes are important in neurodegenerative diseases: An hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development
61. Animal model of Alzheimer-like vascular pathology and inflammatory reaction
62. Practical measures to simplify the Braak tangle staging method for routine pathological screening
63. Tau mutations in familial frontotemporal dementia
64. Induction of epitopes associated with neurofibrillary tangles in clonal mouse neuroblastoma (S20Y) cells
65. Induction of Alzheimer antigens by an uncoupler of oxidative phosphorylation
66. The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease
67. Alzheimer's disease and the amyloid β protein: What is the role of amyloid?
68. Alzheimer's disease: A reexamination of the amyloid hypothesis
69. Immunological treatment of Alzheimer's disease
70. How important is oxidative damage? Lessons from Alzheimer's disease
71. In vitro and in vivo protein oxidation induced by Alzheimer's disease amyloid β-peptide
72. In vitro and in vivo oxidative stress associated with Alzheimer's amyloid β-peptide (1-42)
73. Apolipoprotein E epsilon 4 associated with chronic traumatic brain injury in boxing
74. Involvement of reactive oxygen species in membrane phospholipid breakdown and energy perturbation after traumatic brain injury in the rat
75. Epidemiology of dementia in Rochester, Minnesota
76. Mouse models of mitochondrial disease, oxidative stress, and sensescence
77. +-ATPase activity, glucose transport, and glutamate transport induced by amyloid-β-peptide and iron
78. A full genome scan for late onset Alzheimer's disease
79. Molecular genetics of Alzheimer's disease
80. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease